{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:18:57Z","timestamp":1774916337277,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1994,5,1]],"date-time":"1994-05-01T00:00:00Z","timestamp":767750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[1994,5]]},"DOI":"10.1378\/chest.105.5.1511","type":"journal-article","created":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T18:28:23Z","timestamp":1194460103000},"page":"1511-1515","source":"Crossref","is-referenced-by-count":13,"title":["Nebulized Ipratropium Bromide in Ventilator-assisted Patients With Chronic Bronchitis"],"prefix":"10.1016","volume":"105","author":[{"given":"Shieh Ching","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sze Piao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuen Shan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.105.5.1511_bib1","first-page":"138","article-title":"Bronchodilatory and circulatory effects of inhaling doses of an anticholinergic drug, ipratropium bromide (Sch 1000)","volume":"56","author":"Simonsson","year":"1975","journal-title":"Scand J Respir Dis"},{"key":"10.1378\/chest.105.5.1511_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1378\/chest.73.4.501","article-title":"Aerosol therapy with Sch 1000: short-term mucociliary clearance in normal and bronchitic subjects and toxicology in normal subjects","volume":"73","author":"Ruffin","year":"1978","journal-title":"Chest"},{"key":"10.1378\/chest.105.5.1511_bib3","series-title":"New directions in asthma","first-page":"241","article-title":"Experimental models of asthma","volume":"50","author":"Gold","year":"1975"},{"key":"10.1378\/chest.105.5.1511_bib4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/thx.19.5.406","article-title":"Variation of drug action on airway obstruction in man","volume":"19","author":"Altounyan","year":"1964","journal-title":"Thorax"},{"key":"10.1378\/chest.105.5.1511_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/thx.23.1.46","article-title":"A comparison of responses to bronchodilator drugs in chronic bronchitis and chronic asthma","volume":"23","author":"Crompton","year":"1968","journal-title":"Thorax"},{"key":"10.1378\/chest.105.5.1511_bib6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/bmj.1.5955.430","article-title":"Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma","volume":"1","author":"Petrie","year":"1975","journal-title":"BMJ"},{"key":"10.1378\/chest.105.5.1511_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2125.1978.tb00885.x","article-title":"Comparison of ipratropium bromide and fenoterol in asthma and chronic bror chitis","volume":"6","author":"Marlin","year":"1978","journal-title":"Br J Clin Pharmacol"},{"key":"10.1378\/chest.105.5.1511_bib8","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0140-6736(89)90126-8","article-title":"Nebulized salbutamol with and without ipratropium bromide in acute airflow obstruction","volume":"2","author":"O'Driscoll","year":"1989","journal-title":"Lancet"},{"key":"10.1378\/chest.105.5.1511_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1378\/chest.88.1.24","article-title":"Nebulized ipratropium bromide in the treatment of acute asthma","volume":"88","author":"Bryant","year":"1985","journal-title":"Chest"},{"key":"10.1378\/chest.105.5.1511_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0002-9343(87)90378-0","article-title":"Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airway disease in the emergency room","volume":"82","author":"Rebuck","year":"1987","journal-title":"Am J Med"},{"key":"10.1378\/chest.105.5.1511_bib11","first-page":"762","article-title":"Definitions and classifications of chronic bronchitis, asthma and pulmonary emphysema","volume":"85","author":"American","year":"1962","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.105.5.1511_bib12","first-page":"658","article-title":"Short-term effects of 0.12 ppm ozone exposure in volunteers with chronic obstructive pulmonary disease","volume":"125","author":"Linn","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.105.5.1511_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/thx.39.4.272","article-title":"Assessment of the clinical usefulness of nebulized ipratropium bromide in patients with chronic airflow limitation","volume":"39","author":"Brown","year":"1984","journal-title":"Thorax"},{"key":"10.1378\/chest.105.5.1511_bib14","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1378\/chest.71.3.324","article-title":"Bronchodilator action of the anticholinergic drug, ipratropium bromide (Sch 1000), as an aerosol in chronic bronchitis and asthma","volume":"71","author":"Baigelman","year":"1977","journal-title":"Chest"},{"key":"10.1378\/chest.105.5.1511_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1378\/chest.98.2.295","article-title":"Severe exacerbations of COPD and asthma: incremental benefit of adding ipratropium to usual therapy","volume":"98","author":"Patrick","year":"1990","journal-title":"Chest"},{"key":"10.1378\/chest.105.5.1511_bib16","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1399-6576.1987.tb02638.x","article-title":"Effect of ipratropium bromide aerosol on respiratory function in patients under ventilator treatment","volume":"31","author":"Wegener","year":"1987","journal-title":"Acta Anesthesiol Scand"},{"key":"10.1378\/chest.105.5.1511_bib17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1152\/jappl.1967.22.3.402","article-title":"An effect of isoproterenol on ventilation-perfusion in asthmatic versus normal subjects","volume":"22","author":"Knudson","year":"1967","journal-title":"J Appl Physiol"},{"key":"10.1378\/chest.105.5.1511_bib18","first-page":"511","article-title":"Ventilation-perfusion inequality in asymptomatic asthma","volume":"118","author":"Wagner","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.105.5.1511_bib19","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1164\/ajrccm\/136.5.1091","article-title":"Effects of an anticholinergic bronchodilator on arterial blood gases of hypoxemic patients with chronic obstructive pulmonary disease: comparison with a beta-adrenergic agent","volume":"136","author":"Gross","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.105.5.1511_bib20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/jappl.1971.31.5.651","article-title":"Sympathetic versus parasympathetic nervous regulation of airways in dogs","volume":"31","author":"Cabezas","year":"1971","journal-title":"J Appl Physiol"},{"key":"10.1378\/chest.105.5.1511_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/thx.34.1.51","article-title":"Bronchodilatation and the site of airway resistance in severe chronic bronchitis","volume":"34","author":"Douglas","year":"1979","journal-title":"Thorax"},{"key":"10.1378\/chest.105.5.1511_bib22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1152\/jappl.1970.29.2.236","article-title":"Factors influencing pulmonary resistance","volume":"29","author":"Vincent","year":"1970","journal-title":"J Appl Physiol"},{"key":"10.1378\/chest.105.5.1511_bib23","first-page":"746","article-title":"Predominant site of flow limitation and mechanisms of postexertional asthma","volume":"42","author":"McFadden","year":"1977","journal-title":"Respir Environ Exercise Physiol"},{"key":"10.1378\/chest.105.5.1511_bib24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1164\/ajrccm\/141.2.440","article-title":"Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients: comparison of dose to the lungs","volume":"141","author":"Fuller","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.105.5.1511_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00003246-198502000-00005","article-title":"Aerosol delivery in intubated, mechanically ventilated patients","volume":"13","author":"MacIntyre","year":"1985","journal-title":"Crit Care Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216387396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216387396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,4]],"date-time":"2019-05-04T07:24:16Z","timestamp":1556954656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369216387396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1994,5]]}},"alternative-id":["S0012369216387396"],"URL":"https:\/\/doi.org\/10.1378\/chest.105.5.1511","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[1994,5]]}}}